Squarepoint Ops LLC Makes New $130,000 Investment in Nektar Therapeutics (NASDAQ:NKTR)
Squarepoint Ops LLC acquired a new position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 139,758 shares of the biopharmaceutical company’s stock, valued at approximately $130,000. Several other hedge funds and other institutional investors also recently […]
Squarepoint Ops LLC acquired a new position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 139,758 shares of the biopharmaceutical company’s stock, valued at approximately $130,000. Several other hedge funds and other institutional investors also recently […]
